Drug
niraparib
Marketed as ZEJULA.
Generic name
niraparib
Brand names
ZEJULA
First FDA approval
2023-04-26
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA214876 | ZEJULA | 2023-04-26 | GLAXOSMITHKLINE |
Manufacturers
GLAXOSMITHKLINE
Frequently asked questions
When was niraparib FDA approved?
Earliest FDA approval on record: 2023-04-26.
What brand names are sold as niraparib?
ZEJULA.
Sources
Appeal a niraparib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com